Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: Possible role for dendritically released dopamine

Journal of Neuroscience

Volumn 21, Issue 15, 2001, Pages 5841-5846

  Ranaldi, Robert ^a   Wise, Roy A ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Dendritic release; Drug abuse; Motivation; Operant learning; Progressive ratio schedule; Reinforcement

Indexed keywords

DOPAMINE 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; DENDRITE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; VENTRAL TEGMENTUM;

EID: 0035425683     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-15-05841.2001     Document Type: Article

References (70)

1. Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study
2. Neuronal activity in monkey striatum related to the expectation of predictable environmental events
3. Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens
4. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience?
5. 2) receptors
6. Catecholaminergic brainstem regulatory systems
7. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis
8. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393
9. Dopamine D1 receptors facilitate transmitter release
10. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
11. Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: A microdialysis study in freely moving rats
12. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-D-aspartate receptors
13. Autoradiographic mapping of brain 5-HT2A binding sites in P and in AA alcohol-preferring rats
14. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with noradrenergic blockers phentolamine and phenoxybenzamine
15. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
16. Pattern of expression of the serotonin 2C receptor messenger RNA in the basal ganglia of adult rats
17. Haloperidol induces a partial reinforcement extinction effect in rats: Implications for a dopamine involvement in food reward
18. A partial reinforcement extinction effect in water-reinforced rats intermittently treated with haloperidol
19. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems
20. Drugs and reinforcement mechanisms: A critical review of the catecholamine theory
21. Pimozide-induced extinction of intracranial self-stimulation: Response patterns rule out motor or performance deficits
22. Catecholamines and self-stimulation: Reward and performance effects dissociated
23. Pimozide attenuates lever pressing for water reinforcement in rats
24. Selective localization of striatal D1 receptors to striatonigral neurons
25. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
26. 5-HT receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain
27. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization
28. SCH 23390: The first selective dopamine D1 antagonist
29. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
30. Nigral dopaminergic mechanisms in drug-induced circling
31. The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin
32. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
33. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya
34. D1 receptors modulate glutamate transmission in the ventral tegmental area
35. Cellular and molecular mechanisms of drug dependence
36. MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine
37. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists
38. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors
39. Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area
40. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
41. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat
42. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement
43. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement
44. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine
45. Molecular diversity of glutamate receptors and implications for brain function
46. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat
47. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats
48. Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats
49. Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy
50. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
51. A neural substrate of prediction and reward
52. Prefrontal cortical efferents in the rat synapse on unlableled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
53. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey
54. 3H]aminobutyric acid release?
55. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area
56. Microinjections of Sch 23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine
57. A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons
58. Catecholamine theories of reward: A critical review
59. Neurobiology of addiction
60. Localization of drug reward mechanisms by intracranial injections
61. Brain dopamine and reward
62. Neuroleptic-induced "anhedonia" in rats: Pimozide blocks reward quality of food
63. Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes
64. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward
65. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats
66. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy
67. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: Changes after D-amphetamine
68. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra
69. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens